ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Washington University in St. Louis at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Washington University in St. Louis takes part in 4 sessions at ESMO 2026 in Madrid. Its work spans gastrointestinal and genitourinary cancers, alongside brain tumours and biomarkers. It examines treatments for biliary tract, bladder and kidney cancers, and whether changes in a blood marker track glioblastoma activity.
| Organization | ESMO 2026 Attendance |
|---|---|
Washington University in St. Louis St. Louis, MO | |
Private research university in St. Louis, Missouri, with a school of medicine and a cancer centre. | Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 LDH kinetics as a biomarker of disease activity in glioblastoma treated with porphyrin metabolite activation (PoMA) Sarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology Poster Fri Oct 23 15:15–16:00 |
Find decision makers at Washington University in St. Louis
Tell us what you sell and we’ll find the people at Washington University in St. Louis most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction